New Board Members
Paul J. Jannetto, Ph.D., DABCC, FACB, M.T.(ASCP)
Dr. Jannetto is a Senior Associate Consultant at the Mayo Clinic (Rochester, MN) where he serves as the Co-Director for both the Toxicology and Drug Monitoring Laboratory and Metals Laboratory. Previously, he was an Associate Professor of Pathology at the Medical College of Wisconsin (Milwaukee, WI) where he functioned as the Director of Clinical Chemistry/Toxicology at Dynacare Laboratories (Milwaukee, WI). He earned his BS in Clinical Laboratory Science from the University of Wisconsin-Milwaukee and worked five years as a Medical Technologist for Medical Science Laboratories before entering graduate school. He then earned a Ph.D. in Pharmacology and Toxicology at the Medical College of Wisconsin. He is board-certified by the American Board of Clinical Chemistry and American Society for Clinical Pathology. His clinical and scientific interests are centered on Clinical Chemistry/Toxicology, Forensic Toxicology, Therapeutic Drug Monitoring, Laboratory Management, and Pharmacogenomics.
Dr. Jannetto has been actively involved in the American Association for Clinical Chemistry (AACC) where he has participated in the TDM/Toxicology, Management Sciences, Personalized Medicine, Critical and POCT, and Molecular Pathology divisions. In the past, he has served on the local level as the Chair of the Chicago Section of AACC, and the national level as a member of the Nominating Committee and Chair of the House of Delegates. Dr. Jannetto is also a member of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology and was the President of the Midwest Association for Toxicology and Therapeutic Drug Monitoring.
Alison Woodworth, PhD, DABCC, FACB
Dr. Woodworth is an Assistant Professor of Pathology, Microbiology, and Immunology, Director of Esoteric Chemistry, and Associate Director of Clinical Chemistry at Vanderbilt University Medical Center in Nashville, Tennessee. She is a Diplomate of the American Board of Clinical Chemistry, and serves on the ABCC Board of Directors. She serves as Director of the ComACC certified clinical chemistry fellowship program at Vanderbilt, where she also teaches residents, medical students and medical technologists. Dr. Woodworth has been actively involved in AACC since 2003 and has served on the AACC press board and AMOC. She has also been chair of the AACC Southeast section and was recently elected to serve on its board of delegates. She received the 2013 SYCL Service Award for outstanding contributions to the AACC. She is a fellow of the National Academy of Clinical Biochemistry and currently serves as chair of the editorial board for the NACB Scientific Shorts Committee and was recently elected to the Board of Directors. Her active translational research focuses on biomarker discovery in the areas of Maternal/Fetal Medicine and Sepsis and has produced multiple publications and awards, including the NACB distinguished abstract award and best abstract awards from the Industry and Maternal/Fetal Medicine division. Dr. Woodworth enjoys speaking about clinical chemistry; she has been invited to speak at several local, regional, national, and international meetings and has won the AACC outstanding speaker award for the past three years.